[HTML][HTML] Goals of COPD treatment: Focus on symptoms and exacerbations

CF Vogelmeier, M Roman-Rodriguez, D Singh… - Respiratory …, 2020 - Elsevier
Chronic obstructive pulmonary disease (COPD) is currently a leading cause of death
worldwide, and its burden is expected to rise in the coming years. Common COPD …

Choosing the right inhaler for your asthma or COPD patient

OS Usmani - Therapeutics and clinical risk management, 2019 - Taylor & Francis
Appropriate selection and correct use of inhalation devices is an integral component in the
management of asthma and chronic obstructive pulmonary disease (COPD). It is well known …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Validation of the 'Test of the Adherence to Inhalers'(TAI) for asthma and COPD patients

V Plaza, C Fernández-Rodríguez, C Melero… - Journal of aerosol …, 2016 - liebertpub.com
Abstract Background: To validate the 'Test of Adherence to Inhalers'(TAI), a 12-item
questionnaire designed to assess the adherence to inhalers in patients with COPD or …

An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease

BR Celli, M Decramer, JA Wedzicha… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

Management of chronic obstructive pulmonary disease: A review focusing on exacerbations

SG Bollmeier, AP Hartmann - American Journal of Health …, 2020 - academic.oup.com
Purpose Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity
and mortality in the United States. Exacerbations—acute worsening of COPD symptoms …

Digital technologies and adherence in respiratory diseases: the road ahead

JD Blakey, BG Bender, AL Dima… - European …, 2018 - Eur Respiratory Soc
Outcomes for patients with chronic respiratory diseases remain poor despite the
development of novel therapies. In part, this reflects the fact that adherence to therapy is low …

New inhaler devices-the good, the bad and the ugly

F Lavorini, GA Fontana, OS Usmani - Respiration, 2014 - karger.com
Drug delivery to the lungs is an effective way of targeting inhaled therapeutic aerosols and
treating obstructive airway diseases, such as asthma and chronic obstructive pulmonary …

[HTML][HTML] Conversational agents as mediating social actors in chronic disease management involving health care professionals, patients, and family members: multisite …

T Kowatsch, T Schachner, S Harperink, F Barata… - Journal of medical …, 2021 - jmir.org
Background: Successful management of chronic diseases requires a trustful collaboration
between health care professionals, patients, and family members. Scalable conversational …

[HTML][HTML] What we mean when we talk about adherence in respiratory medicine

B Vrijens, AL Dima, E Van Ganse… - The Journal of Allergy …, 2016 - Elsevier
Adequate medication adherence is key for optimal benefit of pharmacological treatments. A
wealth of research has been conducted to understand and identify opportunities to intervene …